Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Tranexamic Acid”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,459 records · Page 81Linked to original sources

[Dental extraction in patients with bleeding disorders. Proposal of a protocol based on the type of anesthesia used].

INTRODUCTION: The authors propose a protocol to avoid bleeding complications in patients with bleeding disorders. MATERIAL AND METHOD: When a general anesthesia or trunk nerve infiltration is indicated, clotting factor concentrates are to be used in patients with severe bleeding disorders. Desmopressin is to be used in patients with mild bleeding disorders but who are good responders and in patients with thrombopathy. An antifibrinolytic treatment and a fibrin glue are also used. Ninety-six patients underwent 107 extractions with this protocol. RESULTS: Only two patients had bleeding complications requiring an additional treatment. DISCUSSION: In case of bleeding disorders, the treatment depends on disease severity and type of anesthesia. A general treatment (clotting factor concentrates or desmopressin) is indicated with general anesthesia and with local anesthesia in severe bleeding disorders, but not absolutely necessary with local anesthesia in mild bleeding disorders. However, desmopressin can used in all good responders.

Adolescent↗

Strategies for managing anticoagulated patients requiring dental extractions: an exercise in evidence-based clinical practice.

Evidence-based clinical practice requires the development and refinement of literature searching, appraisal skills, and clinical experience. Answering clinical questions using evidence-based methods can be time-intensive, but as one becomes more familiar with the methods, it becomes a fairly straightforward process. For example, it took less than an hour to complete the initial steps of this exercise and arrive at an initial recommendation for Ms. J. Oftentimes, the clinician does not have an hour to find an answer. Fortunately, there are more and more resources available that summarize reviews of clinical questions, so individual practitioners can rapidly access the information they need. Recently, I saw a patient who presented with a preauricular mass. During the visit, a pathologist performed a fine needle aspiration (FNA) to obtain a specimen for diagnosis. Much to our surprise, the FNA results suggested a diagnosis of melanoma. Not being a melanoma expert, I signed on to the computer, went to Up To Date, searched using the keyword "melanoma," and found the information I needed in under a minute. Before the patient left our office, he was scheduled for all the tests and imaging studies needed to maximize his initial appointment with the melanoma specialist. Central to evidence-based clinical practice is the explicit enumeration and balancing of risks and benefits. Evidence is never enough for making clinical decisions. We need to integrate our clinical values and preferences with the patient's values and preferences to render compassionate, informed treatment decisions.

Anticoagulants↗

Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.

BACKGROUND: Recent studies suggest that cetraxate possesses anti-Helicobacter pylori (H. pylori) activity. We therefore conducted this pilot study to investigate the efficacy of a cetraxate-based triple therapy and to compare the regimen with proton pump inhibitor-based triple therapy. METHODS: From April 2001 to January 2002, a total of 58 H. pylori-infected patients were randomly assigned to 1 of 2 regimens for 1 week: cetraxate plus clarithromycin and amoxicillin (CCA group) or pantoprazole plus clarithromycin and amoxicillin (PCA group). Follow-up endoscopy was performed at 8 weeks after the end of treatment to assess the treatment response. RESULTS: Intention-to-treat analysis showed that the eradication rates of the CCA group (n = 27) and PCA group (n = 31) were 70.4% and 93.5%, respectively. The CCA group had a significantly lower eradication rate than the PCA group (p = 0.03). Per-protocol analysis also showed similar results (69.2% vs. 96.7%, p = 0.01). However, the frequency of adverse events in the CCA group was lower than that of the PCA group (3.7% vs. 25.8%, p = 0.03). Univariate analysis showed that the eradication rate was significantly related to proton pump inhibitor therapy (93.5% vs. 70.4%, p = 0.03 ) and smoking habit (66.7 % vs. 88.4%, p = 0.05), but multivariate analysis disclosed that proton pump inhibitor therapy was the only independent factor predicting treatment success (p < 0.05). CONCLUSIONS: Cetraxate-based triple therapy is less effective than pantoprazole-based triple therapy in the treatment of H. pylori infection. However, the former has a lower frequency of adverse effects than the latter.

2-Pyridinylmethylsulfinylbenzimidazoles↗

Menorrhagia.

Explore the source record for details and available documents.

Anti-Inflammatory Agents, Non-Steroidal↗

Menorrhagia.

Explore the source record for details and available documents.

Anti-Inflammatory Agents, Non-Steroidal↗